But shouldn't the local healthcare provider be the
Post# of 148276
(Total Views: 558)
Posted On: 04/03/2022 5:13:53 PM
Re: chazzledazzle #121486
But shouldn't the local healthcare provider be the one reporting to FAERS for the other trials and not Amarex? Or is the entire healthcare adverse event reporting just a sham?
8 of the 9 reports for leronlimab were reported by "Heathcare Professional".
8 of the 9 reports for leronlimab were reported by "Heathcare Professional".
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼